Evidence map›Paper›PMID 32901079›Full record

ArticleScientific reports2020

Behavioral effects of SGK1 knockout in VTA and dopamine neurons.

Marie A Doyle, Ali R Stark, Geza Fejes-Tóth, Aniko Náray-Fejes-Tóth, Michelle S Mazei-Robison

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. The role of serum/glucocorticoid-regulated kinase 1 in brain function following cerebral ischemia.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2024
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Marie A DoyleNeuroscience Program, Michigan State University, 766 Service Rd, ISTB 5017, East Lansing, MI, 48824, USA.
Ali R StarkNeuroscience Program, Michigan State University, 766 Service Rd, ISTB 5017, East Lansing, MI, 48824, USA.
Geza Fejes-TóthDepartment of Molecular and Systems Biology, Dartmouth University, Hanover, USA.
Aniko Náray-Fejes-TóthDepartment of Molecular and Systems Biology, Dartmouth University, Hanover, USA.
Michelle S Mazei-RobisonNeuroscience Program, Michigan State University, 766 Service Rd, ISTB 5017, East Lansing, MI, 48824, USA. mazeirob@msu.edu.
Michigan State University · USDartmouth College · US

Funding

Interdisciplinary Training Program in NeuroscienceT32NS044928 · NINDS · MICHIGAN STATE UNIVERSITY · PI SISK, CHERYL L. · 2002 to 2016
$2.0M
Neurobiological Mechanisms Underlying Stress-Induced Changes in Opiate RewardR01DA039895 · NIDA · MICHIGAN STATE UNIVERSITY · PI MAZEI-ROBISON, MICHELLE SUZANNE · 2016 to 2020
$1.7M
NIDA NIH HHS R01 DA039895NINDS NIH HHS T32 NS044928
6 · The paper itself

Abstract

Drugs of abuse cause significant neuroadaptations within the ventral tegmental area (VTA), with alterations in gene expression tied to changes in reward behavior. Serum- and glucocorticoid-inducible kinase 1 (SGK1) transcription, catalytic activity, and phosphorylation are upregulated in the VTA by chronic cocaine or morphine treatment, positioning SGK1 as a critical mediator of reward behavior. Using transgenic mouse models, we investigated the effect of SGK1 knockout in the VTA and in dopamine (DA) neurons to evaluate the necessity of protein expression for natural and drug reward behaviors. SGK1 knockdown in the VTA did not impact reward behaviors. Given VTA cellular heterogeneity, we also investigated a DA neuron-specific SGK1 knockout (KO). DA SGK1 KO significantly decreased body weight of adult mice as well as increased general locomotor activity; however, reward behaviors were similarly unaltered. Given that SGK1 mutants virally overexpressed in the VTA are capable of altering drug-associated behavior, our current results suggest that changes in SGK1 protein signaling may be distinct from expression. This work yields novel information on the impact of SGK1 deletion, critical for understanding the role of SGK1 signaling in the central nervous system and evaluating SGK1 as a potential therapeutic target for treatment of substance use disorders.

Indexed as

RewardAnimalsBehavior, AnimalCocaineDopaminergic NeuronsDopamine Uptake InhibitorsFemaleImmediate-Early ProteinsMaleMiceMice, Inbred C57BLMice, KnockoutProtein Serine-Threonine KinasesSerum-Glucocorticoid Regulated KinasesSignal TransductionVentral Tegmental AreaCocaineDopamine Uptake InhibitorsImmediate-Early ProteinsProtein Serine-Threonine KinasesSerum-Glucocorticoid Regulated Kinases

Identifiers

PMID32901079
PMCPMC7478959
OpenAlexW3084377766

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.